Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience.
Horgan C, Elmoamly S, McIlroy G, Davies D, Kaparou M, Giles H, Xenou E, Kishore B, Lovell R, Nikolousis E, Shankara P, Kanellopoulos A. Horgan C, et al. Among authors: kanellopoulos a. Leuk Lymphoma. 2019 Dec;60(12):3075-3077. doi: 10.1080/10428194.2019.1607323. Epub 2019 May 13. Leuk Lymphoma. 2019. PMID: 31079514 No abstract available.
Reduced-intensity conditioning allogeneic transplantation after salvage treatment with DT-PACE in myeloma patients relapsing early after autologous transplant.
Randall K, Kaparou M, Xenou E, Paneesha S, Kishore B, Kanellopoulos A, Lovell R, Holder K, Suhr J, Baker L, Ryan L, Nikolousis E. Randall K, et al. Among authors: kanellopoulos a. Eur J Haematol. 2017 Oct;99(4):300-305. doi: 10.1111/ejh.12917. Epub 2017 Jul 20. Eur J Haematol. 2017. PMID: 28632322
Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia.
Kanellopoulos A, Kaparou M, Xenou E, Paneesha S, Kishore B, Lovell R, Holder K, Suhr J, Baker L, Ryan L, Nikolousis E. Kanellopoulos A, et al. Bone Marrow Transplant. 2018 Dec;53(12):1518-1521. doi: 10.1038/s41409-018-0297-z. Epub 2018 Aug 16. Bone Marrow Transplant. 2018. PMID: 30116019
A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant.
Horgan C, Kanellopoulos A, Paneesha S, Kishore B, Lovell R, Nikolousis E. Horgan C, et al. Among authors: kanellopoulos a. Hematol Rep. 2019 Feb 25;11(1):7800. doi: 10.4081/hr.2019.7800. eCollection 2019 Feb 19. Hematol Rep. 2019. PMID: 30915202 Free PMC article.
Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation.
McIlroy G, Nikolousis E, Abou-Zeid N, Shankara P, Kishore B, Kaparou M, Lovell R, Elmoamly S, Davies D, Horgan C, Shenouda A, Kanellopoulos A. McIlroy G, et al. Among authors: kanellopoulos a. Leuk Lymphoma. 2020 Jan;61(1):202-205. doi: 10.1080/10428194.2019.1650177. Epub 2019 Aug 11. Leuk Lymphoma. 2020. PMID: 31402762 No abstract available.
COVID-19 in bone marrow transplant recipients: reflecting on a single centre experience.
Kanellopoulos A, Ahmed MZ, Kishore B, Lovell R, Horgan C, Paneesha S, Lloyd R, Salhan B, Giles H, Chauhan S, Venkatadasari I, Khakwani M, Murthy V, Xenou E, Dassanayake H, Srinath S, Kaparou M, Nikolousis E. Kanellopoulos A, et al. Br J Haematol. 2020 Jul;190(2):e67-e70. doi: 10.1111/bjh.16856. Epub 2020 Jun 23. Br J Haematol. 2020. PMID: 32469077 Free PMC article. No abstract available.
First case of near haploid philadelphia negative B-Cell acute lymphoblastic leukaemia relapsing as acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
Horgan C, Kartsios C, Nikolousis E, Shankara P, Kishore B, Lovell R, Murthy V, Rudzki Z, Dyer S, Holtom P, Thompson G, Kaparou M, Xenou E, Lloyd R, Venkatadasari I, Kanellopoulos AG. Horgan C, et al. Leuk Res Rep. 2020 Jun 18;14:100213. doi: 10.1016/j.lrr.2020.100213. eCollection 2020. Leuk Res Rep. 2020. PMID: 32612922 Free PMC article.
Autoimmune Cytopenias Developing Late Post Alemtuzumab-Based Allogeneic Stem Cell Transplantation: Presentation of Short Case Series from a Transplant Center.
Lloyd R, Nikolousis E, Kishore B, Lovell R, Shankara P, Zeid NA, Horgan C, Panteliadou AK, McIlroy G, Xenou E, Kaparou M, Holder K, Murthy V, Kanellopoulos A. Lloyd R, et al. Among authors: kanellopoulos a. Cell Transplant. 2020 Jan-Dec;29:963689720950641. doi: 10.1177/0963689720950641. Cell Transplant. 2020. PMID: 32806929 Free PMC article.
ERRATUM: A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant.
Horgan C, Kanellopoulos A, Paneesha S, Kishore B, Lovell R, Nikolousis E. Horgan C, et al. Among authors: kanellopoulos a. Hematol Rep. 2020 Nov 16;12(2):8995. doi: 10.4081/hr.2020.8995. eCollection 2020 Nov 16. Hematol Rep. 2020. PMID: 33282167 Free PMC article. No abstract available.
Management of Allogeneic Stem Cell Transplantation for High-Risk AML following SARS-CoV-2 Associated Pancytopenia with Marked Bone Marrow Biopsy Alterations.
Kaparou M, Rudzki Z, Giles H, Murthy V, Srinath S, Lloyd R, Ahmed MZ, Salhan B, Chauhan S, Kishore B, Lovell R, Horgan C, Paneesha S, Xenou E, Lokare A, Ewing J, Dassanayake H, Nikolousis E, Kanellopoulos A. Kaparou M, et al. Among authors: kanellopoulos a. Case Rep Hematol. 2021 Jan 21;2021:8843063. doi: 10.1155/2021/8843063. eCollection 2021. Case Rep Hematol. 2021. PMID: 33510919 Free PMC article.
249 results